Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study

Morag Griffin,Richard J. Kelly, Mathilde Gavillet, Petra Muus,Britta Hoechsmann,W. Jason Cummings, John Efthimiou,William Pullman,Hubert Schrezenmeier,Jens Panse

Blood（2024）

Cited 0|Views1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined